Company SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
0.405 USD -0.17% Intraday chart for SeaStar Medical Holding Corporation +18.59% -8.52%

Business Summary

SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Number of employees: 12

Managers

Managers TitleAgeSince
Chief Executive Officer 51 18-12-31
Director of Finance/CFO 61 Jan. 09
Chief Operating Officer - 22-12-01
Chief Tech/Sci/R&D Officer 51 22-06-30
Corporate Officer/Principal 56 22-10-27

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 20-12-31
Chairman 64 -
Director/Board Member 60 20-12-31
Director/Board Member 63 21-12-31
Director/Board Member 60 21-12-31
Chief Executive Officer 51 18-12-31
Director/Board Member 58 18-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 75,419,458 66,508,578 ( 88.18 %) 0 88.18 %

Shareholders

NameEquities%Valuation
DOW INC.
6.830 %
4,449,841 6.830 % 2 M $
2,587,500 3.972 % 1 M $
Morgan Stanley Smith Barney LLC
2.164 %
1,410,000 2.164 % 681 030 $
837,819 1.286 % 404 667 $
Geode Capital Management LLC
1.074 %
699,539 1.074 % 337 877 $
Millennium Management LLC
1.057 %
688,401 1.057 % 332 498 $
Vanguard Global Advisers LLC
0.4870 %
317,257 0.4870 % 153 235 $
BlackRock Institutional Trust Co. NA
0.3502 %
228,118 0.3502 % 110 181 $
Goldman Sachs & Co. LLC
0.3407 %
221,936 0.3407 % 107 195 $
Kevin Chung
0.3179 %
207,100 0.3179 % 100 029 $
NameEquities%Valuation
Ayrton Capital LLC
-
250,000 - 23 500 $
Boothbay Fund Management LLC
-
245,200 - 23 049 $
Linden Advisors LP
-
218,073 - 20 499 $
Walleye Capital LLC
-
145,109 - 13 640 $
LMR Partners LLP
-
125,000 - 11 750 $
Walleye Trading LLC
-
96,806 - 9 100 $
EHP Funds, Inc.
-
93,651 - 8 803 $
HRT Financial LLC
-
89,550 - 8 418 $
Equitec Proprietary Markets LLC
-
80,399 - 7 558 $
SkyView Investment Advisors LLC
-
64,658 - 6 078 $

Company contact information

Seastar Medical Holding Corp.

3513 Brighton Boulevard Suite 410

80216, Denver

+

http://www.seastarmedical.com
address SeaStar Medical Holding Corporation(ICU)
  1. Stock Market
  2. Equities
  3. ICU Stock
  4. Company SeaStar Medical Holding Corporation